Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Mar;28(3):723-725.
doi: 10.1681/ASN.2016111173. Epub 2017 Jan 3.

Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease

Carl P Walther  1 , Sankar D Navaneethan  2   3
Affiliations
Editorial

Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease

Carl P Walther et al. J Am Soc Nephrol. 2017 Mar.
No abstract available

Keywords: Inflammation; chronic kidney disease; interleukins; vascular disease.

PubMed Disclaimer

Comment on

  • IL-1 Inhibition and Vascular Function in CKD.
    Nowak KL, Chonchol M, Ikizler TA, Farmer-Bailey H, Salas N, Chaudhry R, Wang W, Smits G, Tengesdal I, Dinarello CA, Hung AM. Nowak KL, et al. J Am Soc Nephrol. 2017 Mar;28(3):971-980. doi: 10.1681/ASN.2016040453. Epub 2016 Sep 19. J Am Soc Nephrol. 2017. PMID: 27647856 Free PMC article. Clinical Trial.

References

    1. Amdur RL, Feldman HI, Gupta J, Yang W, Kanetsky P, Shlipak M, Rahman M, Lash JP, Townsend RR, Ojo A, Roy-Chaudhury A, Go AS, Joffe M, He J, Balakrishnan VS, Kimmel PL, Kusek JW, Raj DS; CRIC Study Investigators: Inflammation and progression of CKD: The CRIC Study. Clin J Am Soc Nephrol 11: 1546–1556, 2016 - PMC - PubMed
    1. Anders HJ: Of inflammasomes and alarmins: IL-1β and IL-1α in Kidney Disease. J Am Soc Nephrol 27: 2564–2575, 2016 - PMC - PubMed
    1. Lovell DJ, Giannini EH, Reiff AO, Kimura Y, Li S, Hashkes PJ, Wallace CA, Onel KB, Foell D, Wu R, Biedermann S, Hamilton JD, Radin AR: Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis. Arthritis Rheum 65: 2486–2496, 2013 - PubMed
    1. Nowak KL, Chonchol M, Ikizler TA, Farmer-Bailey H, Salas N, Chaudhry R, Wang W, Smits G, Tengesdal I, Dinarello CA, Hung AM: IL-1 Inhibition and Vascular Function in CKD. J Am Soc Nephrol 28: 971–980, 2017 - PMC - PubMed
    1. de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators: Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369: 2492–2503, 2013 - PMC - PubMed

LinkOut - more resources